PDPS Trademark
Serial Number: 97933969 • Registration: 7709587
Trademark Classes
Class 1 - Chemicals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Class 5 - Pharmaceuticals
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Class 40 - Treatment & Processing
Treatment of materials
Class 42 - Computer & Scientific
Scientific and technological services; industrial analysis and research services
Owner Contact Info
3-25-23 Tonomachi, Kawasaki-Ku
Kawasaki-Shi, Kanagawa 210-0821 , JP
Entity Type: 03
Legal Representation
Correspondence Address
Harris A. Wolin MYERS WOLIN, LLC
100 SOUTH JEFFERSON ROAD, SUITE 202
WHIPPANY, NJ 07981-1009
United States
Trademark Details
Filing Date
May 12, 2023
Registration Date
March 4, 2025
Published for Opposition
January 14, 2025
Goods & Services
Manufacture of synthetic peptides to the order and specification of others; Peptide synthesis for others, namely, manufacture of synthetic peptides to the order and specification of others; Manufacture of pharmaceuticals and chemicals to the order and specification of others; Manufacture of synthetic proteins to the order and specification of others; Amino acid synthesis for others, namely, manufacture of amino acids to the order and specification of others
Synthesized peptides used in drug discovery of various pharmaceuticals for the treatment of various to different diseases and medical conditions; Chemical preparations used in drug discovery for the treatment of various diseases and medical conditions and for pharmaceutical purposes; Central nervous system drugs, namely, pharmaceutical preparations for the treatment of various diseases and medical conditions affecting the central nervous system; Peripheral nerve drugs, namely, pharmaceutical agents for the treatment of various diseases and medical conditions affecting the peripheral nervous system; Drugs affecting sensory organs, namely, pharmaceutical agents for the treatment of various diseases and medical conditions affecting sensory organs; Antiallergic drugs, namely, pharmaceutical antiallergic preparations and substances; Cardiovascular drugs, namely, cardiovascular pharmaceutical preparations; Drugs affecting respiratory organs, namely, pharmaceutical preparations for treating respiratory diseases; Drugs affecting digestive organs, namely, pharmaceutical preparations for the treatment of various diseases and medical conditions affecting digestive organs; Drugs for outer skin, namely, pharmaceutical preparations for the treatment of various diseases and medical conditions for skin care; Pharmaceutical preparations for the treatment of various diseases and medical conditions of Metabolic disorders; Cellular function activating drugs for the treatment of various diseases and medical conditions for medical purposes; Pharmaceutical preparations for the treatment of various diseases and medical conditions for suppressing tumors; diagnostic preparations for medical purposes; Pharmaceutical preparations using synthesized peptides used in drug discovery and pharmaceuticals for the treatment of various diseases and medical conditions for medical purposes; Synthesized proteins and chemical preparations used in drug discovery and pharmaceuticals for the treatment of various diseases and medical conditions for medical purposes
Chemicals for the manufacture of pharmaceuticals; synthesized peptides for scientific and research use; Reagents for biological and chemical purposes and for research purposes, excluding those for medical or veterinary use; Proteins and synthesized peptides used in the research and the development and manufacture of pharmaceuticals and biologicals; Chemical reagents used for the detection, measurement and identification of genetic materials or compounds, excluding those for medical and veterinary use
Testing, examination, namely, inspection and research services in the field of pharmaceuticals, cosmetics, and foods, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of medical organisms or bacteria, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of chemistry, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of medical care, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of biotechnology, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the identification of hit lead peptides, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the identification of hit-lead compounds, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the analysis and synthesis of peptides, and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the field of the analysis and synthesis of proteins, and the provision of information or advice thereto; The generation of a library of peptides and the provision of information or advice thereto; Testing, examination, namely, inspection and research services in the fields of pharmaceuticals, cosmetics, foods, medical organisms or bacteria, chemistry, medical care, biotechnology, identification of hit lead peptides, analysis and synthesis of peptides, using automated screening machines and the provision of information or advice thereto; Scientific research in the nature of conduction of clinical trials for others; Quality control of peptides used in drug development; Advice on quality control of peptides used in drug development